Kunze kwekuti kudya kwako kuchizadza mu calcium, calcium uye vitamini D zvigadzirwa zvinokurudzirwa kuti zviwane zvakakwana kubva kuna Evista (Raloxifene).
Maererano neNational Osteoporosis Foundation, vanhu vakuru 50 nevanopfuura vanoda 1 200 mg ye calcium uye 800 kusvika ku1000 IU ye vitamini D3 zuva rega rega. Izvo zvinoshandiswa zvinobva kune calcium ndeyekudya-calcium-yakawanda, zvakadai semishonga yemakisi, tofu, mamwe mimwe miriwo miriwo uye zvokudya izvo zvakasimbiswa ne calcium .
Chii chinonzi Evista?
Evista rudzi rwemishonga yemishonga inonzi "selective estrogen receptor modulator" (SERM). Inoshandiswa kurapa kana kudzivirira osteoporosis kuvakadzi mushure mokunge apera.
Apo iwe unopinda nepamuviri, muviri wako unobereka iserojeni shoma, iyo, mune vamwe vakadzi, inogona kuita kuti mapfupa ave akaonda uye ave asina simba. Evista inoshanda kuburikidza nekubatsira kuita kuti mapfupa ako ave akasimba uye zvisingagoni kudarika. Inobatsira kudzivisa osteoporosis nekuvaka pfupa nekudzikisa kudonha kwefupa kunogona kuitika mushure mekupera kwemwedzi.
Evista Inodzivirira Breast Cancer?
Maererano neU.S. Food and Drug Administration (FDA), kana uine osteoporosis kana uri pangozi yekenza yepese, Evista inogona kushandiswa kuderedza mikana yako yekuwana kenza yepamu inoputika .
Kunyange zvazvo Evista isingazobvisi zvachose njodzi yako yekuwana kenza yemazamu, chiremba wako anogona kufungidzira mikana yako nekutsvaga nezvehutano hwako, kusanganisira makore ako, nhoroondo yemhuri yekenza yemazamu (muna amai vako, hanzvadzi, kana mwanasikana), uye nhoroondo yeiyo chero ipi zvayo yemazamu , kunyanya bhiopsy isina kukodzera.
Iwe uye chiremba wako unokwanisa kubva ipapo uone kana zvibatsiro zvekutora Evista zvinopfuura mungozi dzehutano.
Ndeapi Ngozi dzekutora Evista?
Mune vamwe vakadzi, migumisiro yakakomba inogona kuitika paunotora Evista, kusanganisira ropa ravha uye chirwere.
Nengozi yakawedzerwa yekuvhara ropa mumakumbo (yakadzika yevhein thrombosis) nemapapu (embromism embolism) yakataurwa neEvista.
Kana iwe uine kana uine ropa mumakumbo ako kana mapapu, haufaniri kutora Evista. Kunyarara kwenguva yakareba (yakadai sokugara padziri mumotokari refu kana rwendo rwendege, kana kuti uri pamubhedha mushure mekuvhiyiwa) kunogona kuwedzera dambudziko rekuvhara ropa.
Kana uine chirwere chepfungwa kana uri pangozi yekurwadziwa kwepfungwa, iwe unogona kuva nehuwandu hwekufa kubva pakurova kana iwe uchitora Evista.
Kana iwe ikozvino uchitora Evista, rega kuitora uye kudana chiremba wako kana uine:
- marwadzo omumakumbo kana manzwiro ekudziya mutsipa wako wezasi (mhuru)
- kuzvimba kwemakumbo ako, maoko, kana tsoka
- kushungurudzika kwepfupa, kusuruvara kwepfufu, kana ropa kana uchikandira
- kushanduka kamwe kamwe mune zvawakaratidzwa, zvakadai sokurasikirwa kwemaonero kana kuonekwa kwakasvibiswa
Ndekupi Kwandingawana Mamwe Mashoko Pamusoro peEvista?
Kuti udzidze zvakawanda pamusoro peEvista, verenga mharidzo yeEvista mishonga yaunofanira kupiwa kana iwe uzadza chiremba chako chekutanga uye nguva imwe neimwe yaunowana. Kana iwe usingawani mutungamiri wemishonga, bvunza chiremba wako kuti atore rimwe rako. Iwe unogona kuwanawo mutungamiri paIndaneti pawebsite yeEli Lilly neChina ( PDF ).
Mukuwedzera kune nyevero pamusoro peEvista kubva kuDFA, mutungamiri wemishonga unokuzivisawo nezvemigumisiro uye kusangana kwemishonga.
Kana uine mibvunzo pamusoro pekushandisa Evista, taura nachiremba wako.
Mamwe Mashoko Pamusoro peOsteoporosis:
- National Osteoporosis Foundation (NOF) - webhusaiti yeNOF inopa ruzivo rwakanakisisa kune vatengi nezvekudzivirira uye kurapa kwehutachiona hwehutachiona, kusanganisira mazano ekuchengetedza maitiro ekudzivirira kuputika.
- Osteoporosis - in-deep, report illustrated about osteoporosis kubva kuThe Health Encyclopedia.
Sources:
FDA Inobvumira Zvishandiso Zvitsva zveEvista. FDA News Release. US Food and Drug Administration. http://www.fda.gov/cder/Offices/OODP/whatsnew/raloxifene.htm
Evhangeri: Pfungwa huru yekunyora mashoko. Dhiyabhorosi reDAA Drug drug. US Food and Drug Administration. http://www.fda.gov/cder/foi/label/2007/022042lbl.pdf